$632M
$1.18 Million
0.0% of portfolio
43
Q2 2025
Added 38.71%
-
$285 Million
0.0% of portfolio
-
Q2 2025
Added 707.21%
$0
$8.98 Million
0.0% of portfolio
515
Q2 2025
Reduced 98.22%
$1.19B
$32.1 Million
0.0% of portfolio
3,602
Q2 2025
Reduced 51.57%
$2.04B
$2.39 Million
0.0% of portfolio
268
Q2 2025
Added 104.58%
$638M
$146 Million
0.0% of portfolio
6,447
Q2 2025
Added 0.62%
$2.07B
$4.07 Million
0.0% of portfolio
49
Q2 2025
Added 133.33%
$3.76B
$5.91 Million
0.0% of portfolio
135
Q2 2025
Reduced 33.5%
$1.62B
$36.8 Million
0.0% of portfolio
3,058
Q2 2025
Added 60.36%
$728M
$1.26 Million
0.0% of portfolio
34
Q2 2025
Added 54.55%
-
$78.1 Million
0.0% of portfolio
-
Q2 2025
Added 18.72%
$20.9B
$28.1 Million
0.0% of portfolio
49
Q2 2025
Reduced 54.63%
$142M
$303,000
0.0% of portfolio
23
Q2 2025
New
-
$1.26 Million
0.0% of portfolio
-
Q2 2025
Reduced 80.18%
-
$144 Million
0.0% of portfolio
-
Q2 2025
Added 3,977.63%
-
$2.59 Million
0.0% of portfolio
-
Q2 2025
Added 2,288.89%
$2.27B
$65.6 Million
0.0% of portfolio
7,939
Q2 2025
Added 58.31%
$1.18B
$83.4 Million
0.0% of portfolio
853
Q2 2025
Added 19.8%
$2.08B
$49 Million
0.0% of portfolio
4,267
Q2 2025
Added 65.07%
Liberty Media Corp Liberty C
-
$256 Million
0.0% of portfolio
-
Q2 2025
Added 20.31%
Liberty Media Corp Liberty A
-
$106 Million
0.0% of portfolio
-
Q2 2025
Added 21.33%
Liberty Media Corp Lib New A
-
$97.4 Million
0.0% of portfolio
-
Q2 2025
Added 18.89%
$5.35B
$9.95 Million
0.0% of portfolio
328
Q2 2025
Reduced 77.39%
$457M
$247,000
0.0% of portfolio
10
Q2 2025
Added 100.0%
$211M
$4.89 Million
0.0% of portfolio
359
Q2 2025
Added 37.55%
-
$2.55 Million
0.0% of portfolio
-
Q2 2025
Reduced 4.88%
$2.58B
$52.4 Million
0.0% of portfolio
461
Q2 2025
Added 49.19%
$178M
$340,000
0.0% of portfolio
26
Q2 2025
New
-
$602,000
0.0% of portfolio
-
Q2 2025
New
$1.75B
$9.14 Million
0.0% of portfolio
1,768
Q2 2025
Added 28.96%
$1.14B
$3.64 Million
0.0% of portfolio
26
Q2 2025
Added 116.67%
$282M
$6.95 Million
0.0% of portfolio
444
Q2 2025
Added 55.24%
Ligand Pharmaceuticals Inc Con
-
$0
0.0% of portfolio
-
Q1 2025
New
Ligand Pharmaceuticals Inc Con
-
$0
0.0% of portfolio
-
Q1 2025
New
$541M
$1.66 Million
0.0% of portfolio
72
Q2 2025
Reduced 84.04%
$707M
$1.06 Million
0.0% of portfolio
91
Q2 2025
Reduced 57.87%
$1.54B
$3.75 Million
0.0% of portfolio
26
Q2 2025
Reduced 74.0%
-
$222 Million
0.0% of portfolio
-
Q2 2025
Added 47.37%
$109M
$4.61 Million
0.0% of portfolio
631
Q2 2025
Added 65.18%
-
$29.8 Million
0.0% of portfolio
-
Q2 2025
New
$1.55B
$1.84 Million
0.0% of portfolio
148
Q2 2025
Added 111.43%
$1.46B
$17.2 Million
0.0% of portfolio
578
Q2 2025
Added 430.28%
$1.74B
$190 Million
0.0% of portfolio
5,737
Q2 2025
Added 8,592.42%
$1.42B
$409,000
0.0% of portfolio
-
Q2 2025
Added 368.42%
$123M
$2.8 Million
0.0% of portfolio
2,204
Q2 2025
New
$306M
$3.75 Million
0.0% of portfolio
206
Q2 2025
Added 60.94%
$38.6M
$1.31 Million
0.0% of portfolio
1,138
Q2 2025
New
$3.81B
$174 Million
0.0% of portfolio
82,691
Q2 2025
Added 49.56%
$4.09B
$22 Million
0.0% of portfolio
5,031
Q2 2025
Reduced 96.8%
$112M
$2.72 Million
0.0% of portfolio
1,232
Q2 2025
New